|
US5271927A
(en)
*
|
1986-02-13 |
1993-12-21 |
Celltech Limited |
Antibody conjugates with macrocyclic ligands
|
|
US4877868A
(en)
*
|
1986-03-12 |
1989-10-31 |
Neorx Corporation |
Radionuclide antibody coupling
|
|
ATE106898T1
(de)
*
|
1987-03-26 |
1994-06-15 |
Neorx Corp |
Metall-radionuklid-markierte proteine und glykoproteine zur diagnose und therapie.
|
|
US5091514A
(en)
*
|
1987-03-26 |
1992-02-25 |
Neorx Corporation |
Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
|
|
US4965392A
(en)
*
|
1987-03-26 |
1990-10-23 |
Neorx Corporation |
Chelating compounds for metal-radionuclide labeled proteins
|
|
DE3710730A1
(de)
*
|
1987-03-31 |
1988-10-20 |
Schering Ag |
Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
|
|
US5177192A
(en)
*
|
1987-04-02 |
1993-01-05 |
Centocor, Incorporated |
Method for labeling antibodies with a metal ion
|
|
WO1988007382A2
(en)
*
|
1987-04-02 |
1988-10-06 |
Centocor Cardiovascular Imaging Partners, L.P. |
Method for labelling antibodies with a metal ion
|
|
US5053493A
(en)
*
|
1987-04-02 |
1991-10-01 |
Centocor Cardiovascular Imaging Partners, L.P. |
Method for labeling antibodies with a metal ion
|
|
US5021556A
(en)
*
|
1987-07-22 |
1991-06-04 |
Neorx Corporation |
Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
|
|
EP0300431A3
(de)
*
|
1987-07-22 |
1990-06-27 |
Neorx Corporation |
Methode zur Bindung von radionukliden Anschwefel enthaltende Chelate
|
|
GB8719041D0
(en)
*
|
1987-08-12 |
1987-09-16 |
Parker D |
Conjugate compounds
|
|
GB8719042D0
(en)
|
1987-08-12 |
1987-09-16 |
Parker D |
Conjugate compounds
|
|
AU2068588A
(en)
*
|
1987-08-12 |
1989-02-16 |
Immunomedics Inc. |
Preparation of radiolabeled conjugates
|
|
US4933470A
(en)
*
|
1987-10-05 |
1990-06-12 |
Neorx Corporation |
Method of synthesis of vicinal diamines
|
|
US5648471A
(en)
*
|
1987-12-03 |
1997-07-15 |
Centocor, Inc. |
One vial method for labeling antibodies with Technetium-99m
|
|
DE68923274T2
(de)
*
|
1988-02-09 |
1995-11-09 |
Mallinckrodt Inc |
Verfahren zur herstellung eines mit metall-radionuklid-markierten proteins.
|
|
US5202451A
(en)
*
|
1988-02-17 |
1993-04-13 |
Neorx Corporation |
Anchimeric radiometal chelating compounds
|
|
US5075099A
(en)
*
|
1988-05-31 |
1991-12-24 |
Neorx Corporation |
Metal radionuclide chelating compounds for improved chelation kinetics
|
|
US4988496A
(en)
*
|
1988-05-31 |
1991-01-29 |
Neorx Corporation |
Metal radionuclide chelating compounds for improved chelation kinetics
|
|
US5089249A
(en)
*
|
1988-06-10 |
1992-02-18 |
Neorx Corporation |
Conjugates for bone imaging and bone cancer therapy
|
|
US5202109A
(en)
*
|
1988-06-10 |
1993-04-13 |
Neorx Corporation |
Conjugates for bone imaging and bone cancer therapy
|
|
US4839467A
(en)
*
|
1988-06-15 |
1989-06-13 |
University Of Cincinnati |
Radioactive rhenium complexed to 2-hydroxy isobutyric acid
|
|
US5218128A
(en)
*
|
1988-06-15 |
1993-06-08 |
Centocor, Inc. |
Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
|
|
US5180816A
(en)
*
|
1988-08-24 |
1993-01-19 |
Centocor |
One vial method for labeling protein/linker conjugates with technetium-99M
|
|
US5066789A
(en)
*
|
1988-09-30 |
1991-11-19 |
Neorx Corporation |
Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
|
|
DE68924783T2
(de)
*
|
1988-09-30 |
1996-03-28 |
Neorx Corp |
Wässrige additivsysteme, verfahren und polymerteilchen.
|
|
US4925650A
(en)
*
|
1988-11-16 |
1990-05-15 |
Mallinckrodt, Inc. |
Technetium -99m complex for examining the renal function
|
|
US5342936A
(en)
*
|
1989-02-10 |
1994-08-30 |
David Parker |
Tetra-aza macrocycles and processes for their preparation
|
|
DE69024826T2
(de)
*
|
1989-02-10 |
1996-06-27 |
Celltech Therapeutics Ltd |
Aza-Macrozyklen und Verfahren zu deren Herstellung
|
|
US5053503A
(en)
*
|
1989-02-17 |
1991-10-01 |
Centocor |
Chelating agents
|
|
US5206370A
(en)
|
1989-02-24 |
1993-04-27 |
Johnson Matthey, Inc. |
Certain pyridyl hydrazines and hydrazides useful for protein labeling
|
|
US5162240A
(en)
*
|
1989-06-16 |
1992-11-10 |
Hitachi, Ltd. |
Method and apparatus of fabricating electric circuit pattern on thick and thin film hybrid multilayer wiring substrate
|
|
US5247077A
(en)
*
|
1989-06-23 |
1993-09-21 |
Celltech Limited |
Tri-aza macrocycles and processes for their preparation
|
|
US5443816A
(en)
*
|
1990-08-08 |
1995-08-22 |
Rhomed Incorporated |
Peptide-metal ion pharmaceutical preparation and method
|
|
DE3930674A1
(de)
*
|
1989-09-11 |
1991-03-21 |
Diagnostikforschung Inst |
Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
|
|
US5162505A
(en)
*
|
1989-09-19 |
1992-11-10 |
Centocor |
Proteins modified with positively charged carriers and compositions prepared therefrom
|
|
US5112953A
(en)
*
|
1989-12-29 |
1992-05-12 |
Neorx Corporation |
Radiolabeled proteins for diagnostic or therapeutic use
|
|
US5185433A
(en)
*
|
1990-04-09 |
1993-02-09 |
Centocor, Inc. |
Cross-linking protein compositions having two or more identical binding sites
|
|
NZ237868A
(en)
*
|
1990-04-18 |
1994-04-27 |
Celltech Ltd |
Paramagnetic metal complexes of 1,4,7,10-tetracyclododecane derivatives and their use as nmr imaging agents
|
|
US5684135A
(en)
*
|
1990-04-18 |
1997-11-04 |
Celltech Therapeutics Limited |
Conjugate compounds containing aza-macro-cycles and processes for their preparation
|
|
US5080883A
(en)
*
|
1990-05-11 |
1992-01-14 |
Mallinckrodt, Inc. |
99 mtcn3s-conjugated anti-bibrin monoclonal antibody as an in vivo diagnostic agent for imaging
|
|
US5382654A
(en)
*
|
1992-02-05 |
1995-01-17 |
Mallinckrodt Medical, Inc. |
Radiolabelled peptide compounds
|
|
DE69126124T2
(de)
*
|
1990-09-28 |
1997-08-28 |
Neorx Corp |
Polymere träger zur freisetzung kovalent gebundener wirkstoffe
|
|
US5645815A
(en)
|
1991-02-08 |
1997-07-08 |
Diatide, Inc. |
Radiolabled compounds for thrombus imaging
|
|
US6107459A
(en)
*
|
1991-02-08 |
2000-08-22 |
Diatide, Inc. |
Technetium-99m labeled peptides for diagnostic imaging
|
|
US5736122A
(en)
*
|
1991-02-08 |
1998-04-07 |
Diatide, Inc. |
Technetium-99m labeled peptides for thrombus imaging
|
|
US5443815A
(en)
*
|
1991-11-27 |
1995-08-22 |
Diatech, Inc. |
Technetium-99m labeled peptides for imaging
|
|
US5561220A
(en)
*
|
1991-02-08 |
1996-10-01 |
Diatech, Inc. |
Technetium-99m labeled peptides for imaging inflammation
|
|
US5965107A
(en)
*
|
1992-03-13 |
1999-10-12 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging
|
|
US6019958A
(en)
*
|
1991-02-08 |
2000-02-01 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging inflammation
|
|
US5849261A
(en)
*
|
1991-02-08 |
1998-12-15 |
Diatide, Inc. |
Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
|
|
DE69230525T2
(de)
*
|
1991-02-08 |
2000-06-21 |
Diatide, Inc. |
Technetium-99m markierte Polypeptide zur Bildformung
|
|
US5997844A
(en)
*
|
1991-02-08 |
1999-12-07 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging
|
|
GB9113487D0
(en)
*
|
1991-06-21 |
1991-08-07 |
Amersham Int Plc |
Agents for hypoxic cells
|
|
US5225180A
(en)
*
|
1991-09-10 |
1993-07-06 |
Diatech, Inc. |
Technetium-99m labeled somatostatin-derived peptides for imaging
|
|
US5783170A
(en)
*
|
1991-11-27 |
1998-07-21 |
Diatide, Inc. |
Peptide-metal chelate conjugates
|
|
US5643549A
(en)
*
|
1992-02-20 |
1997-07-01 |
Rhomed Incorporated |
Leukostimulatory agent for in vivo leukocyte tagging
|
|
US5326856A
(en)
*
|
1992-04-09 |
1994-07-05 |
Cytogen Corporation |
Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
|
|
US5508020A
(en)
|
1992-06-05 |
1996-04-16 |
Diatech, Inc. |
Technetium-99M labeled peptides for imaging
|
|
US5968476A
(en)
*
|
1992-05-21 |
1999-10-19 |
Diatide, Inc. |
Technetium-99m labeled peptides for thrombus imaging
|
|
DE4301871A1
(de)
*
|
1993-01-13 |
1994-07-14 |
Diagnostikforschung Inst |
Neue Mittel zur Diagnose von Gefäßerkrankungen
|
|
US5879657A
(en)
*
|
1993-03-30 |
1999-03-09 |
The Dupont Merck Pharmaceutical Company |
Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
|
|
DE4310999C2
(de)
*
|
1993-03-31 |
1996-07-18 |
Diagnostikforschung Inst |
Bifunktionelle chalkogenatom-unterbrochene Chelatbildner vom Typ XN¶1¶S¶1¶X' für radioaktive Isotope und deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
|
|
CA2158249A1
(en)
*
|
1993-03-31 |
1994-10-13 |
James W. Brodack |
Radiopharmaceutical formulations having non-stannous reductants
|
|
DE4311023C2
(de)
*
|
1993-03-31 |
1996-05-02 |
Diagnostikforschung Inst |
Bifunktionelle chalkogenatom-unterbrochene Chelatbildner von Typ XN¶1¶S¶1¶O¶1¶ für radioaktive Isotope, deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
|
|
DE4311022C2
(de)
*
|
1993-03-31 |
1996-07-11 |
Diagnostikforschung Inst |
Bifunktionelle chalkogenatom-unterbrochene Chelatbildner vom Typ S¶3¶N¶2¶ für radioaktive Isotope und deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
|
|
WO1994026294A1
(en)
*
|
1993-05-14 |
1994-11-24 |
Mallinckrodt Medical, Inc. |
Ligand precursors for incorporation into peptides
|
|
US5449761A
(en)
*
|
1993-09-28 |
1995-09-12 |
Cytogen Corporation |
Metal-binding targeted polypeptide constructs
|
|
WO1995034315A1
(en)
*
|
1994-06-16 |
1995-12-21 |
Neorx Corporation |
Radiolabeled annexin-galactose conjugates
|
|
US5942210A
(en)
*
|
1994-11-15 |
1999-08-24 |
Cytogen Corporation |
Methods for lyoprotecting a macromolecule using tricine
|
|
DE19505960A1
(de)
*
|
1995-02-21 |
1996-08-22 |
Deutsches Krebsforsch |
Konjugat zur individuellen Dosierung von Arzneimitteln
|
|
US5977322A
(en)
|
1995-06-14 |
1999-11-02 |
The Regents Of The University Of California |
High affinity human antibodies to tumor antigens
|
|
DE19536780A1
(de)
*
|
1995-09-21 |
1997-03-27 |
Diagnostikforschung Inst |
Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ XSNY für radioaktive Isotope
|
|
CA2241009A1
(en)
*
|
1995-12-28 |
1997-07-10 |
Paul C. Zamecnik |
Cardiovascular and thrombus imaging agents, methods and kits
|
|
US6187286B1
(en)
*
|
1996-12-27 |
2001-02-13 |
The General Hospital Corporation |
Tumor imaging agents, methods and kits
|
|
US6960457B1
(en)
|
1997-09-04 |
2005-11-01 |
Stanford University |
Reversible immobilization of arginine-tagged moieties on a silicate surface
|
|
WO2002029410A2
(en)
|
2000-10-06 |
2002-04-11 |
Quantum Dot Corporation |
Cells having a spectral signature, and methods of preparation and use thereof
|
|
US20050059031A1
(en)
|
2000-10-06 |
2005-03-17 |
Quantum Dot Corporation |
Method for enhancing transport of semiconductor nanocrystals across biological membranes
|
|
EP1343973B2
(de)
|
2000-11-16 |
2020-09-16 |
California Institute Of Technology |
Vorrichtung und verfahren zur durchführung von assays und screening mit hohem durchsatz
|
|
US6972324B2
(en)
|
2001-05-18 |
2005-12-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Antibodies specific for CD44v6
|
|
EP1406493A4
(de)
|
2001-06-11 |
2006-06-14 |
Xenoport Inc |
Verabreichung von mitteln über den pept-2-transporter
|
|
WO2003048295A1
(en)
|
2001-11-30 |
2003-06-12 |
Fluidigm Corporation |
Microfluidic device and methods of using same
|
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
UA81634C2
(ru)
|
2002-07-18 |
2008-01-25 |
Хеликс Биофарма Корп. |
Фармацевтическая композиция уреазы для ингибирования роста раковых клеток и ее применение
|
|
US20050043233A1
(en)
|
2003-04-29 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
|
|
GB0416062D0
(en)
*
|
2004-07-19 |
2004-08-18 |
Amersham Plc |
Improved N4 chelator conjugates
|
|
BRPI0507169A
(pt)
|
2004-02-02 |
2007-06-26 |
Ambrx Inc |
polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
|
|
US7632924B2
(en)
|
2004-06-18 |
2009-12-15 |
Ambrx, Inc. |
Antigen-binding polypeptides and their uses
|
|
WO2006091231A2
(en)
|
2004-07-21 |
2006-08-31 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
|
EP2399893B1
(de)
|
2004-12-22 |
2018-08-15 |
Ambrx, Inc. |
Zusammensetzungen und Verfahren mit sowie Verwendungen von nichtnatürlichen Aminosäuren und Polypeptiden
|
|
BRPI0519430A2
(pt)
|
2004-12-22 |
2009-02-10 |
Ambrx Inc |
hormânio do crescimento humano modificado
|
|
DK2339014T3
(en)
|
2005-11-16 |
2015-07-20 |
Ambrx Inc |
Methods and compositions comprising non-natural amino acids
|
|
CN106008699A
(zh)
|
2006-09-08 |
2016-10-12 |
Ambrx公司 |
经修饰的人类血浆多肽或Fc骨架和其用途
|
|
CN101678090B
(zh)
|
2007-03-07 |
2012-04-11 |
乌第有限合伙公司 |
用于预防和治疗自身免疫病的组合物和方法
|
|
CN107501407B
(zh)
|
2007-03-30 |
2022-03-18 |
Ambrx公司 |
经修饰fgf-21多肽和其用途
|
|
CA2699394C
(en)
|
2007-09-17 |
2020-03-24 |
The Regents Of The University Of California |
Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
|
|
CN101868246A
(zh)
|
2007-09-21 |
2010-10-20 |
加利福尼亚大学董事会 |
被导靶的干扰素显示强的细胞凋亡和抗肿瘤活性
|
|
MX2010005317A
(es)
|
2007-11-20 |
2010-06-02 |
Ambrx Inc |
Polipeptidos de insulina modificados y sus usos.
|
|
MX344166B
(es)
|
2008-02-08 |
2016-12-07 |
Ambrx Inc |
Leptina-polipeptidos modificados y sus usos.
|
|
CN102159230A
(zh)
|
2008-07-23 |
2011-08-17 |
Ambrx公司 |
经修饰的牛g-csf多肽和其用途
|
|
AU2009296267B2
(en)
|
2008-09-26 |
2013-10-31 |
Ambrx, Inc. |
Non-natural amino acid replication-dependent microorganisms and vaccines
|
|
BR122012024318A2
(pt)
|
2008-09-26 |
2019-07-30 |
Ambrx, Inc. |
Polipeptídeos modificados de eritropoetina animal e seus usos
|
|
AU2010210600B2
(en)
|
2009-02-06 |
2016-07-14 |
C3 Jian, Inc. |
Calcium-binding agents induce hair growth and/or nail growth
|
|
BR112012015597A2
(pt)
|
2009-12-21 |
2017-01-31 |
Ambrx Inc |
peptídeos de somatotropina suínos modificados e seus usos
|
|
MX349301B
(es)
|
2009-12-21 |
2017-07-21 |
Ambrx Inc |
Polipéptidos de somatotropina bovina modificados y sus usos.
|
|
US9782454B2
(en)
|
2010-04-22 |
2017-10-10 |
Longevity Biotech, Inc. |
Highly active polypeptides and methods of making and using the same
|
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
|
EA030886B1
(ru)
|
2010-08-17 |
2018-10-31 |
Амбркс, Инк. |
Модифицированные полипептиды релаксина, содержащие некодируемую в природе аминокислоту, связанную с полимером, и их применение
|
|
US11246915B2
(en)
|
2010-09-15 |
2022-02-15 |
Applied Molecular Transport Inc. |
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
|
|
RU2593715C2
(ru)
|
2010-09-15 |
2016-08-10 |
Рэндэлл Дж. МРСНИ |
Системы и способы доставки биоактивных средств с применением транспортных последовательностей, происходящих от бактериального токсина
|
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
|
KR20130124487A
(ko)
|
2010-09-29 |
2013-11-14 |
유티아이 리미티드 파트너쉽 |
생체적합성, 생흡수성 나노구를 사용하는 자가면역 질병의 치료방법
|
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
|
CN105388287A
(zh)
|
2011-03-11 |
2016-03-09 |
内布拉斯加大学董事委员会 |
冠状动脉疾病的生物标志物
|
|
DK2694095T3
(en)
|
2011-04-05 |
2018-05-28 |
Longevity Biotech Inc |
COMPOSITIONS COMPREHENSIVE GLUCAGON ANALOGS AND METHODS FOR PREPARING AND USING THE SAME
|
|
CN110078789A
(zh)
|
2011-05-27 |
2019-08-02 |
Ambrx 公司 |
含有非天然氨基酸连接的海兔毒素衍生物的组合物、涉及该海兔毒素衍生物的方法及其用途
|
|
KR102356286B1
(ko)
|
2011-05-27 |
2022-02-08 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
|
|
MY168411A
(en)
*
|
2012-02-03 |
2018-11-09 |
Lg Chemical Ltd |
Method for preparing compound by novel michael addition reaction using water or various acids as additive
|
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
|
CN108727466B
(zh)
|
2012-06-07 |
2023-04-28 |
Ambrx公司 |
前列腺特异性膜抗原抗体药物结合物
|
|
CN104619350A
(zh)
|
2012-06-14 |
2015-05-13 |
Ambrx公司 |
结合到核受体配体多肽的抗psma抗体
|
|
KR102190832B1
(ko)
|
2012-06-19 |
2020-12-15 |
암브룩스, 인코포레이티드 |
항cd70 항체 약물 컨쥬게이트
|
|
US9603948B2
(en)
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
WO2014145718A2
(en)
|
2013-03-15 |
2014-09-18 |
Longevity Biotech, Inc. |
Peptides comprising non-natural amino acids and methods of making and using the same
|
|
US11559580B1
(en)
|
2013-09-17 |
2023-01-24 |
Blaze Bioscience, Inc. |
Tissue-homing peptide conjugates and methods of use thereof
|
|
US10519247B2
(en)
|
2013-11-01 |
2019-12-31 |
Board Of Regents,The University Of Texas System |
Targeting HER2 and HER3 with bispecific antibodies in cancerous cells
|
|
AU2014343379B2
(en)
|
2013-11-04 |
2019-02-14 |
Uti Limited Partnership |
Methods and compositions for sustained immunotherapy
|
|
CN106470707A
(zh)
|
2014-05-07 |
2017-03-01 |
应用分子运输有限责任公司 |
用于口服递送生物活性货物的cholix毒素衍生的融合分子
|
|
CN114805532A
(zh)
|
2014-10-24 |
2022-07-29 |
百时美施贵宝公司 |
修饰的fgf-21多肽及其用途
|
|
EP3291832B1
(de)
|
2015-05-06 |
2025-09-03 |
UTI Limited Partnership |
Nanopartikelzusammensetzungen zur verzögerten therapie
|
|
US10193422B2
(en)
|
2015-05-13 |
2019-01-29 |
Makita Corporation |
Power tool
|
|
MX2018005232A
(es)
|
2015-11-03 |
2018-08-15 |
Ambrx Inc |
Anticuerpos anti-cd3 novedosos y sus usos.
|
|
SI3383920T1
(sl)
|
2015-11-30 |
2024-06-28 |
The Regents Of The University Of California |
Dostava tumorsko specifičnega koristnega tovora in imunska aktivacija z uporabo humanega protitelesa, ki cilja visoko specifičen površinski antigen tumorskih celic
|
|
WO2017180789A2
(en)
|
2016-04-12 |
2017-10-19 |
Blaze Bioscience, Inc. |
Methods of treatment using chlorotoxin conjugates
|
|
US12048732B2
(en)
|
2016-04-15 |
2024-07-30 |
Blaze Bioscience, Inc. |
Methods of treating breast cancer
|
|
WO2018089829A1
(en)
|
2016-11-10 |
2018-05-17 |
Fortis Therapeutics, Inc. |
Cd46-specific effector cells and uses thereof
|
|
CA3043277A1
(en)
|
2016-11-11 |
2018-05-17 |
The Regents Of The University Of California |
Anti-cd46 antibodies and methods of use
|
|
JP2020503857A
(ja)
|
2016-12-12 |
2020-02-06 |
セファイド |
自動反応カートリッジにおける統合化イムノpcr及び核酸分析
|
|
EP3565573B1
(de)
|
2017-01-05 |
2023-08-23 |
The Regents of The University of California |
Pac1-rezeptor-agonisten (maxcaps) und verwendungen davon
|
|
PE20191716A1
(es)
|
2017-02-08 |
2019-12-05 |
Bristol Myers Squibb Co |
Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos
|
|
CA3083748A1
(en)
|
2017-11-29 |
2019-06-06 |
Uti Limited Partnership |
Methods of treating autoimmune disease
|
|
CN121513216A
(zh)
|
2018-03-08 |
2026-02-13 |
应用分子转运公司 |
用于经口递送的毒素衍生的递送构建体
|
|
MX2020010104A
(es)
|
2018-03-29 |
2020-11-06 |
Ambrx Inc |
Conjugados de farmaco-anticuerpo anti-antigeno de membrana especifico de prostata (psma) humanizado.
|
|
MX2021002301A
(es)
|
2018-08-28 |
2021-04-28 |
Ambrx Inc |
Bioconjugados de anticuerpo-foliato anti-cd3 y sus usos.
|
|
CA3111576A1
(en)
|
2018-09-11 |
2020-03-19 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and their uses
|
|
JP2022512746A
(ja)
|
2018-10-19 |
2022-02-07 |
アンブルックス,インコーポレイテッド |
インターロイキン-10ポリペプチド複合体、その二量体、およびそれらの使用
|
|
EP4083058A3
(de)
|
2018-11-07 |
2023-01-11 |
Applied Molecular Transport Inc. |
Verabreichungskonstrukte für die transzytose und zugehörige verfahren
|
|
CA3128081A1
(en)
|
2019-02-12 |
2020-08-20 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-tlr agonist conjugates
|
|
MX2022001975A
(es)
|
2019-08-16 |
2022-03-11 |
Applied Molecular Transport Inc |
Composiciones, formulaciones y produccion y purificacion de interleucinas.
|
|
WO2021173889A1
(en)
|
2020-02-26 |
2021-09-02 |
Ambrx, Inc. |
Uses of anti-cd3 antibody folate bioconjugates
|
|
EP4117732A1
(de)
|
2020-03-11 |
2023-01-18 |
Ambrx, Inc. |
Interleukin-2-polypeptidkonjugate und verfahren zur verwendung davon
|
|
EP4192511A1
(de)
|
2020-08-07 |
2023-06-14 |
Fortis Therapeutics, Inc. |
Gegen cd46 gerichtete immunkonjugate und verfahren zur verwendung davon
|
|
JP2023538071A
(ja)
|
2020-08-20 |
2023-09-06 |
アンブルックス,インコーポレイテッド |
抗体-tlrアゴニストコンジュゲート、その方法及び使用
|
|
CA3213805A1
(en)
|
2021-04-03 |
2022-10-06 |
Feng Tian |
Anti-her2 antibody-drug conjugates and uses thereof
|
|
WO2024077277A1
(en)
|
2022-10-07 |
2024-04-11 |
Ambrx, Inc. |
Drug linkers and antibody conjugates thereof
|
|
JP2026504093A
(ja)
|
2023-01-16 |
2026-02-03 |
アンブレツクス・インコーポレイテツド |
抗cd70抗体薬物コンジュゲート
|
|
WO2024178310A1
(en)
|
2023-02-23 |
2024-08-29 |
Ambrx, Inc. |
Trop2-directed antibody-drug conjugates and uses thereof
|
|
AU2024329469A1
(en)
|
2023-08-22 |
2026-04-09 |
Ambrx, Inc. |
Anti-psma adc conjugate compositions and methods of use thereof
|